We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHS
176
Pekin Hardy Strauss
Illinois
– -$276K -6,750 Closed
CC
177
Corton Capital
Ontario, Canada
– -$274K -6,693 Closed
HHGC
178
Hunting Hill Global Capital
New York
– -$242K -5,926 Closed
Deutsche Bank
179
Deutsche Bank
Germany
– -$242K -5,925 Closed
ET
180
Entropy Technologies
New York
– -$239K -5,844 Closed
MSRPS
181
Maryland State Retirement & Pension System
Maryland
– -$220K -5,372 Closed
CIBC Asset Management
182
CIBC Asset Management
Ontario, Canada
– -$208K -5,092 Closed
GH
183
GAM Holding
Switzerland
– -$204K -5,000 Closed
QOP
184
Quinn Opportunity Partners
Virginia
– -$204K -5,000 Closed
Fidelity Investments
185
Fidelity Investments
Massachusetts
– -$200K -4,880 Closed
AB
186
Amalgamated Bank
New York
– -$195K -4,770 Closed
MIM
187
MetLife Investment Management
New Jersey
– -$181K -4,432 Closed
Macquarie Group
188
Macquarie Group
Australia
– -$175K -4,285 Closed
Royal Bank of Canada
189
Royal Bank of Canada
Ontario, Canada
– -$164K -4,020 Closed
TSMHT
190
Thurston Springer Miller Herd & Titak
Indiana
– -$127K -3,107 Closed
CFM
191
Catalyst Funds Management
Australia
– -$114K -2,800 Closed
CF
192
Centaurus Financial
California
– -$114K -2,800 Closed
KBC Group
193
KBC Group
Belgium
– -$86K -2,114 Closed
PCWA
194
Pacific Capital Wealth Advisors
California
– -$73.2K -1,790 Closed
LIM
195
Longfellow Investment Management
Massachusetts
– -$70.5K -1,723 Closed
Wells Fargo
196
Wells Fargo
California
– -$57.9K -1,415 Closed
CF
197
Corebridge Financial
Texas
– -$56.1K -1,372 Closed
Russell Investments Group
198
Russell Investments Group
United Kingdom
– -$46.1K -1,128 Closed
Pacer Advisors
199
Pacer Advisors
Pennsylvania
– -$42.6K -1,043 Closed
Nisa Investment Advisors
200
Nisa Investment Advisors
Missouri
– -$29.3K -717 Closed
6 7
8
9 10

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.